• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Consumer Cyclical·AMARC.BK
Share

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited Stocks

THB 2.96Last Updated 18.09.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 35.64M

THB 2.96
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC), established in Bangkok, Thailand, in 2004, offers a broad spectrum of laboratory services, focusing primarily on the agricultural, food, and pharmaceutical sectors. This subsidiary of Ladprao General Hospital Public Company Limited provides vital support across several key areas. The company delivers extensive testing, inspection, and certification for a diverse range of products, including meat and meat products, fats, oils, pet food, feedstuffs, aquaculture items, crops, and various other food and beverage commodities. They also perform environmental analyses on water, air, and soil samples, as well as potable water and water ice. For the agricultural industry, AMARC specializes in quality control and registration for fertilizers, in addition to conducting efficacy and residue trials and providing registration assistance for hazardous substances and pesticides. In the pharmaceutical realm, their services encompass quality assurance testing, research and development for drugs and raw materials, analysis of product components, drug analysis method validation, and bioequivalence studies. They also support the cosmetics industry with quality assurance, including contaminant and challenge tests, and are involved in developing new testing methodologies for pharmaceutical products. Beyond analytical testing, AMARC offers calibration services for electrical, temperature, chemical, and mechanical metrology, alongside calibrating various medical devices such as electrocardiograms, non-invasive blood pressure devices, patient monitors, and pulse oximeters. Additionally, the company provides expert consultation and training, guiding clients through quality system preparation (including ISO/IEC 17025 standards), inspection, and certification processes, as well as optimizing laboratory tools and equipment. Further services include nutrition labeling, shelf-life assessments, and analysis of food contact materials.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair value on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of AMARC.BK is 3.70 and suggests 25% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.09.2026 21:00

Anthropic Has Chosen a Stock Exchange; OpenAI Is Aiming for $1.2 Trillion: Key Takeaways on IPOs by September 20

20.09.2026 15:01

Does having a lot of money make an investor more rational? Yes, but only to a certain extent

19.09.2026 16:01

Small-Cap Highlights: Management Shuffle at Hugo Boss, LSD's Success, Yoox Outlet's Surge

19.09.2026 13:01

AI: To Accelerate or Slow Down? Revolut Takes on Extortionists; Luxury Is Becoming More Affordable

19.09.2026 03:54

Trump signed a law imposing sanctions on Russia. It will affect major oil importers.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026